SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-270154
Filing Date
2018-09-10
Accepted
2018-09-10 17:22:07
Documents
15
Period of Report
2018-09-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d620797d8k.htm 8-K 38122
2 EX-1.1 d620797dex11.htm EX-1.1 232522
3 EX-4.1 d620797dex41.htm EX-4.1 332062
4 EX-4.2 d620797dex42.htm EX-4.2 488001
5 EX-5.1 d620797dex51.htm EX-5.1 14598
6 EX-99.1 d620797dex991.htm EX-99.1 8949
7 EX-99.2 d620797dex992.htm EX-99.2 11414
8 GRAPHIC g620797dsp69.jpg GRAPHIC 7454
9 GRAPHIC g620797g0910220825289.jpg GRAPHIC 1837
10 GRAPHIC g620797g0910220825414.jpg GRAPHIC 2022
11 GRAPHIC g620797g0910220825507.jpg GRAPHIC 2130
12 GRAPHIC g620797g0910220825616.jpg GRAPHIC 2145
13 GRAPHIC g620797g0910220825726.jpg GRAPHIC 1916
14 GRAPHIC g620797g0910220825835.jpg GRAPHIC 2868
15 GRAPHIC g620797snap1.jpg GRAPHIC 10332
  Complete submission text file 0001193125-18-270154.txt   1170517
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 181063452
SIC: 2834 Pharmaceutical Preparations